trending Market Intelligence /marketintelligence/en/news-insights/trending/biGlxpwNGR4WP_I8Ad-Y6Q2 content esgSubNav
In This List

Apellis Pharmaceuticals names CFO

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Apellis Pharmaceuticals names CFO

Apellis Pharmaceuticals Inc. appointed Timothy Sullivan to serve as CFO.

Sullivan was most recently an observer on Apellis' board for nearly three years while he was a partner at venture capital firm AJU IB Investment, where he led the firm's investments in life sciences companies.